Members of 4 societies published a consensus system of care document containing operator and institutional recommendations and requirements for transcatheter mitral valve interventions.
The TriClip device may be safe and effective for lowering tricuspid regurgitation by 1 grade or more.
Evaluation of skeletal muscle mass may help predict long-term cardiovascular disease (CVD) risk in adults without preexisting CVD.
Coronary computed tomography angiography may consistently improve coronary heart disease outcomes in individuals with chest pain.
A fixed-dose combination pill may be an effective component of a preventive strategy to reduce cardiovascular disease.
This scientific statement released by the American Heart Association covers noninvasive assessment of limb perfusion, including limitations associated with currently available technology.
Dose-dependent relationship seen in a large national cohort of US veterans.
Further studies are needed to determine the threshold of risk at which it is safe to withhold therapy for prevention of atherosclerotic cardiovascular disease in elderly people.
The increased CVD risk found in women with hypertensive pregnancy disorders was associated with conventional risk factors.
The LIFEtime-perspective CardioVascular Disease model can accurately estimate individual-level prognosis and treatment-effects in terms of improved 10-year risk, lifetime risk, and life-expectancy free of cardiovascular disease.
